Replies to post #149662 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Maybe more important, it's only been several days since PFS was recognized by the FDA as a meaningful approvable endpoint for GBM!

Here is a quote from Genentech regarding Avastin receiving full approval for rGBM.

“Glioblastoma is the most common and aggressive form of brain cancer and can be very difficult to treat,” said Sandra Horning, MD, Chief Medical Officer and Head of Global Product Development at Genentech. “Delaying disease progression and reducing the need for corticosteroids over the course of treatment are considered important goals for those impacted by this devastating disease, where patients have limited treatment options.”